Cerebrolysin is a standardised complex mixture of low-molecular-weight neuropeptides and free amino acids derived from the enzymatic proteolysis of purified porcine brain proteins. With an average molecular weight of approximately 1000 g/mol across its peptide fractions, the preparation contains a heterogeneous population of biologically active peptide fragments rather than a single defined compound. The manufacturing process employs controlled enzymatic degradation to generate reproducible peptide profiles, and the preparation is standardised by total peptide and amino acid content. Unlike the single-entity synthetic peptides in this catalogue, Cerebrolysin represents a multi-component neuropeptide preparation with a documented history in preclinical neuroscience research.

Cerebrolysin has been investigated across a broad range of preclinical neuroscience contexts. Published research has characterised the preparation as exhibiting neurotrophic-factor-like activity and multimodal signalling effects, with studies describing interactions with multiple cellular pathways involved in neuronal survival, plasticity, and repair. Published in vitro studies have examined the preparation in neuronal cell culture models, documenting that Cerebrolysin reduces glutamate-induced excitotoxic death of cultured telencephalon neurons in a concentration-dependent manner [1] and that its peptide fraction exerts antiapoptotic effects and maintains neuronal viability under cell-stress conditions in primary cortical neuron cultures [2]. In vivo rodent studies have examined the preparation in models of chronic neurological insult, documenting that Cerebrolysin increases hippocampal neurogenesis and is associated with structural and functional restoration in experimental models of brain injury and neurodegeneration [3], making Cerebrolysin a reference preparation in preclinical neuroscience research examining multimodal peptide-based neurotrophic activity, neuronal survival, and injury-associated neuroregeneration.

Cerebrolysin is manufactured in a cGMP compliant, ISO9001 certified laboratory to verified purity and composition standards. Every batch is independently tested using HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available on request.

Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.

Editorial Team

Dr. Martina Rossi, PhD

Scientific Contributor and Reviewer

Reviewed and approved 14 June 2026

View credentials →